Company Filing History:
Years Active: 1997
Title: Ian G Macreadie: Innovator in Immunogenic Protein Production
Introduction
Ian G Macreadie is a notable inventor based in Templestowe, Australia. He has made significant contributions to the field of immunology through his innovative work on the production of highly immunogenic forms of proteins. His research has implications for vaccine development and disease prevention.
Latest Patents
Ian G Macreadie holds a patent for the "Production of IBDV VP2 in highly immunogenic form." This patent describes a highly immunogenic form of the VP2 structural protein of Infectious Bursal Disease Virus (IBDV). The invention involves producing a high molecular weight aggregated form of VP2 by expressing a nucleotide sequence coding for the VP2 structural protein in a yeast or other eukaryotic host cell. This advancement is crucial for enhancing the immune response in vaccine formulations.
Career Highlights
Ian has dedicated his career to research and innovation in the field of immunology. He is affiliated with the Commonwealth Scientific and Industrial Research Organisation (CSIRO), where he collaborates with other scientists to advance the understanding of viral diseases and develop effective vaccines. His work has been recognized for its potential impact on public health.
Collaborations
Throughout his career, Ian has worked alongside esteemed colleagues such as Ahmed Abdullah Azad and Neil Moreton McKern. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.
Conclusion
Ian G Macreadie's contributions to the field of immunology, particularly through his patent on IBDV VP2, highlight his role as an innovator in protein production. His work continues to influence vaccine development and improve health outcomes.